| Meghan Frankland, PHARMD | |
|
3400 Coors Blvd Nw, Albuquerque, NM 87120-1448 | |
| (505) 836-4111 | |
| Not Available |
| Full Name | Meghan Frankland |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3400 Coors Blvd Nw, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134839137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP00000120 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Meghan Frankland, PHARMD 5801 Eubank Blvd Ne Apt 156, Albuquerque, NM 87111-6189 Ph: () - | Meghan Frankland, PHARMD 3400 Coors Blvd Nw, Albuquerque, NM 87120-1448 Ph: (505) 836-4111 |
News Archive
The locus of male sexual desire has been uncovered in specific regions of brain tissue where a key gene named aromatase is present, reports a new Northwestern Medicine study in mice.
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a desert plant common to the Southwestern United States, exhibit potent anti-parasitic activity against the protozoa responsible for giardia infections and an amoeba that causes an often-lethal form of encephalitis.
Cyprotex PLC, the preclinical ADME Tox services company, today announces the launch of its new in vitro toxicology service, branded as Cyprotox(R). Supporting the new service is an additional 90 square metres of laboratory space at Cyprotex's Macclesfield, UK facility housing the latest technology in multi-parametric automated fluorescent imaging and cellular analysis. This gives Cyprotex's Macclesfield site the same in vitro toxicology capabilities as those of Apredica (Watertown, MA, USA), which Cyprotex acquired on 6 August 2010.
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
› Verified 5 days ago
Dr. Rochelle Fliethman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4710 Jefferson St Ne, Albuquerque, NM 87109 Phone: 505-955-9454 Fax: 505-888-9644 | |
Mr. David Lewis Gottheimer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2625 San Pedro Drive, Albuquerque, NM 87110 Phone: 505-237-9027 | |
Roxanna Love Vick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11825 Lomas Blvd Ne, Albuquerque, NM 87112 Phone: 505-293-9156 Fax: 505-323-1740 | |
Ms. Maria Magdalena Lopez-villa, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5400 Gibson Blvd Se, Albuquerque, NM 87108 Phone: 505-727-5915 Fax: 505-727-1241 | |
Mr. Michael Richardson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4209 San Pedro Dr Ne, 274, Albuquerque, NM 87109 Phone: 505-884-1584 | |
Amanda P Sampson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 | |
Dr. Kendra Saxvik, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 |